1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. COMERA LIFE SCIENCES HOLDINGS INC

Comera Life Sciences Holdings Inc

XNAS: CMRA

Watchlist

Portfolio

Share


Insider Trading disclosures for Comera Life Sciences Holdings Inc

The latest disclosure was made by Cherington Charles in Comera Life Sciences Holdings Inc where a trade of 20,650,908 Warrants to Purchase Common Stock done was reported to US exchanges on Dec. 27, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cherington Charles Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Dec 2023 20,650,908 20,650,908 - - Warrants to Purchase Common Stock
Cherington Charles Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Dec 2023 3,895 3,895 - - Series A Convertible Perpetual Preferred Stock
Robert Mahoney Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.63 per share. 14 Aug 2023 20,000 124,576 - 0.6 12,504 Common Stock
William A. Wexler Director Other type of transaction at price $ 0.00 per share. 11 Aug 2023 6,636 17,698 - 0 Common Stock
James Sherblom Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 30,906 30,906 - - Stock Option (Right to Purchase)
Kirsten Flowers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 39,491 39,491 - - Stock Option (Right to Purchase)
Stuart A. Randle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 56,662 56,662 - - Stock Option (Right to Purchase)
Edward Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 44,642 44,642 - - Stock Option (Right to Purchase)
Roopom Banerjee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 44,642 44,642 - - Stock Option (Right to Purchase)
William A. Wexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2023 27,472 27,472 - - Stock Option (Right to Purchase)
Kirsten Flowers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 7,100 7,100 - - Stock Option (Right to Purchase)
Jeffrey S. Hackman Director, See Remarks. Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 100,000 100,000 - - Stock Option (Right to Purchase)
Neal Muni EVP & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 100,000 100,000 - - Stock Option (Right to Purchase)
Robert Mahoney Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 25,000 25,000 - - Stock Option (Right to Purchase)
Michael G. Campbell EVP & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 25,000 25,000 - - Stock Option (Right to Purchase)
James Sherblom Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 7,100 7,100 - - Stock Option (Right to Purchase)
Edward Sullivan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 7,100 7,100 - - Stock Option (Right to Purchase)
Roopom Banerjee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 7,100 7,100 - - Stock Option (Right to Purchase)
William A. Wexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 7,100 7,100 - - Stock Option (Right to Purchase)
Stuart A. Randle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2023 7,100 7,100 - - Stock Option (Right to Purchase)
Roopom Banerjee Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Jan 2023 20,270 20,270 - - Warrant (Right to Buy)
Roopom Banerjee Director Purchase of securities on an exchange or from another person at price $ 1.23 per share. 04 Jan 2023 20,270 28,956 - 1.2 24,932 Common Stock
Edward Sullivan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Jan 2023 10,979 10,979 - - Warrant (Right to Buy)
Edward Sullivan Director Purchase of securities on an exchange or from another person at price $ 1.23 per share. 04 Jan 2023 10,979 19,665 - 1.2 13,504 Common Stock
James Sherblom Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Jan 2023 81,081 81,081 - - Warrant (Right to Buy)
James Sherblom Director Purchase of securities on an exchange or from another person at price $ 1.23 per share. 04 Jan 2023 81,081 452,244 - 1.2 99,730 Common Stock
Kirsten Flowers Director Purchase of securities on an exchange or from another person at price $ 1.23 per share. 04 Jan 2023 13,513 22,199 - 1.2 16,621 Common Stock
Kirsten Flowers Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Jan 2023 13,513 13,513 - - Warrant (Right to Buy)
Barbara K. Finck Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Jan 2023 6,756 6,756 - - Warrant (Right to Buy)
Barbara K. Finck Director Purchase of securities on an exchange or from another person at price $ 1.23 per share. 04 Jan 2023 6,756 23,033 - 1.2 8,310 Common Stock
Stuart A. Randle Director Purchase of securities on an exchange or from another person at price $ 1.23 per share. 04 Jan 2023 33,783 42,469 - 1.2 41,553 Common Stock
Stuart A. Randle Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Jan 2023 33,783 33,783 - - Warrant (Right to Buy)
Barbara K. Finck Director 31 Dec 2022 37,111 37,111 - - Stock Option (Right to Buy)
Kirsten Flowers Director 31 Dec 2022 44,981 44,981 - - Stock Option (Right to Buy)
Jim Sherblom Director 31 Dec 2022 36,241 36,241 - - Stock Option (Right to Buy)
Edward Sullivan Director 31 Dec 2022 44,981 44,981 - - Stock Option (Right to Buy)
John Yee Director 31 Dec 2022 41,608 41,608 - - Stock Option (Right to Buy)
Roopom Banerjee Director 31 Dec 2022 44,981 44,981 - - Stock Option (Right to Buy)
Stuart A. Randle Director 31 Dec 2022 44,981 44,981 - - Stock Option (Right to Buy)
Janice McCourt Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2022 150,000 150,000 - - Stock Option (Right to Purchase)
Jim Sherblom Director Purchase of securities on an exchange or from another person at price $ 2.03 per share. 12 Sep 2022 50,000 371,163 - 2.0 101,500 Common Stock
Jeffrey S. Hackman Director, See Remarks Purchase of securities on an exchange or from another person at price $ 2.06 per share. 09 Sep 2022 47,600 47,600 - 2.1 98,056 Common Stock
Michael G. Campbell EVP & CFO Purchase of securities on an exchange or from another person at price $ 2.07 per share. 08 Sep 2022 25,000 25,000 - 2.1 51,750 Common Stock
Jeffrey S. Hackman Director, See Remarks. Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2022 300,000 300,000 - - Stock Option (Right to Purchase)
Neal Muni EVP & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2022 50,000 50,000 - - Stock Option (Right to Purchase)
William A. Wexler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2022 14,200 14,200 - - Stock Option (Right to Purchase)
Michael G. Campbell Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 450,000 450,000 - - Stock Option (Right to Purchase)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters